Lung Cancer Clinical Trial

A Study of Stereotactic Radiosurgery (SRS) for People With Lung Cancer That Has Spread to the Brain

Summary

The purpose of the study is to see if stereotactic radiosurgery/SRS is an effective treatment for people with a new diagnosis of brain metastases from small cell lung cancer/SCLC.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Histologic diagnosis of small cell lung cancer
Radiographic diagnosis of up to 10 brain metastases on contrast-enhanced MRI
Age 18 and above
Performance status KPS 60-100/ECOG 0-2
Female patients must be of non-reproductive potential or have a negative serum pregnancy test at the time of enrollment
The patient or legally authorized representative is able to provide informed consent

Exclusion Criteria:

Unable to undergo contrast-enhanced MRI brain or spine
Leptomeningeal disease confirmed on lumbar puncture, MRI brain, or MRI spine
Pregnant or lactating women
Prior brain-directed radiotherapy
Uncontrolled systemic disease without reasonable systemic therapy options felt likely to result in death as observed on CT or PET/CT imaging, no more than 3 months before study enrollment

Study is for people with:

Lung Cancer

Phase:

Phase 2

Estimated Enrollment:

62

Study ID:

NCT05419076

Recruitment Status:

Recruiting

Sponsor:

Memorial Sloan Kettering Cancer Center

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 7 Locations for this study

See Locations Near You

Memorial Sloan Kettering at Basking Ridge
Basking Ridge New Jersey, 07920, United States More Info
Luke Pike, MD
Contact
201-775-7604
Memorial Sloan Kettering Monmouth
Middletown New Jersey, 07748, United States More Info
Luke Pike, MD
Contact
201-775-7604
Memorial Sloan Kettering Bergen
Montvale New Jersey, 07645, United States More Info
Luke Pike, MD
Contact
201-775-7604
Memorial Sloan Kettering Suffolk - Commack
Commack New York, 11725, United States More Info
Luke Pike, MD
Contact
201-775-7604
Memorial Sloan Kettering Westchester
Harrison New York, 10604, United States More Info
Luke Pike, MD
Contact
201-775-7604
Memorial Sloan Kettering Cancer Center (All Protocol Activities)
New York New York, 10065, United States More Info
Luke Pike, MD
Contact
201-775-7604
Memorial Sloan Kettering Nassau
Rockville Centre New York, 11553, United States More Info
Luke Pike, MD
Contact
201-775-7604

How clear is this clinincal trial information?

Study is for people with:

Lung Cancer

Phase:

Phase 2

Estimated Enrollment:

62

Study ID:

NCT05419076

Recruitment Status:

Recruiting

Sponsor:


Memorial Sloan Kettering Cancer Center

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.